GlassScriptPhysician profile
Jason Michael Christopher
NPI 1689296097
$228.90
in general payments reported to CMS, 2019-2025
8 companies · $91.01 in 2025
The $91.01 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.53 · 2024: $121 · 2025: $91.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $66.51 | 2024-2025 | Invega Sustenna, Spravato |
| Alkermes, INC. | $35.18 | 2023-2025 | Lybalvi, Vivitrol |
| Collegium Pharmaceutical, INC. | $31.48 | 2025 | Jornay Pm |
| Lilly USA, LLC | $21.51 | 2025 | Amyvid, Kisunla |
| Neurocrine Biosciences, INC. | $20.95 | 2024 | Ingrezza |
| Tempus Ai, INC | $19.90 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $16.88 | 2024 | Austedo Xr |
| Corium, LLC | $16.49 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.